ABEONA THERAPEUTICS INC. Deferred Tax Liabilities, Property, Plant and Equipment
ABEONA THERAPEUTICS INC. (ABEO) had Deferred Tax Liabilities, Property, Plant and Equipment of $1.33 million as of 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2026-03-17
- 2025-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $1.33M.
- 2019-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $28.00K.
- 2018-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $72.00K.
- 2017-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $28.00K.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment |
|---|---|
| 2025-12-31 | $1.33M 10-K · filed 2026-03-17 |
| 2019-12-31 | $28.00K 10-K · filed 2020-03-16 |
| 2018-12-31 | $72.00K 10-K · filed 2020-03-16 |
| 2017-12-31 | $28.00K 10-K · filed 2019-03-18 |
| 2016-12-31 | $23.00K 10-K · filed 2018-03-16 |
| 2015-12-31 | $25.00K 10-K · filed 2017-03-30 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |